Clinical Trial Update: Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effects of fasinumab on peripheral nerve function in osteoarthritis of the hip or knee; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• Fasinumab (fasinumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 2 | Status: COMPLETED | Results posted: 2023-03-01